Obesity Hypoventilation Syndrome Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194231 | Category: Medical Devices & Consumables | Pages: 67 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Obesity hypoventilation syndrome is defined as alveolar hypoventilation while awake in an obese individual where there is no other cause of the hypoventilation (such as a sedating drug). Ninety percent of people with obesity hypoventilation syndrome (OHS) also have an associated obstructive sleep apnea.The mainstay of treatment in OHS is to provide breathing support, often through the use of continuous positive airway pressure (CPAP) or bilevel.
This report aims to provide a comprehensive presentation of the global market for Obesity Hypoventilation Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Hypoventilation Syndrome Treatment. This report contains market size and forecasts of Obesity Hypoventilation Syndrome Treatment in global, including the following market information:
Global Obesity Hypoventilation Syndrome Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Obesity Hypoventilation Syndrome Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oxygen Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Obesity Hypoventilation Syndrome Treatment include Accord Healthcare Limited, Avet Pharmaceuticals Inc, Nostrum Laboratories Inc, Lannett Co Inc, Strides Pharma Science Limited, X Gen Pharmaceuticals Inc, ResMed, Koninklijke Philips NV and Hikma Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Hypoventilation Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Obesity Hypoventilation Syndrome Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Obesity Hypoventilation Syndrome Treatment Market Segment Percentages, by Type, 2022 (%)
    Oxygen Therapy
    Non-invasive Mechanical Ventilation
    Drug Therapy
    Other
Global Obesity Hypoventilation Syndrome Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Obesity Hypoventilation Syndrome Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinics
    Others
Global Obesity Hypoventilation Syndrome Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Obesity Hypoventilation Syndrome Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Obesity Hypoventilation Syndrome Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Obesity Hypoventilation Syndrome Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Accord Healthcare Limited
    Avet Pharmaceuticals Inc
    Nostrum Laboratories Inc
    Lannett Co Inc
    Strides Pharma Science Limited
    X Gen Pharmaceuticals Inc
    ResMed
    Koninklijke Philips NV
    Hikma Pharmaceuticals
    Lincare Holdings
Outline of Major Chapters:
Chapter 1: Introduces the definition of Obesity Hypoventilation Syndrome Treatment, market overview.
Chapter 2: Global Obesity Hypoventilation Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Obesity Hypoventilation Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Obesity Hypoventilation Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Obesity Hypoventilation Syndrome Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Obesity Hypoventilation Syndrome Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Obesity Hypoventilation Syndrome Treatment Overall Market Size
    2.1 Global Obesity Hypoventilation Syndrome Treatment Market Size: 2022 VS 2029
    2.2 Global Obesity Hypoventilation Syndrome Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Obesity Hypoventilation Syndrome Treatment Players in Global Market
    3.2 Top Global Obesity Hypoventilation Syndrome Treatment Companies Ranked by Revenue
    3.3 Global Obesity Hypoventilation Syndrome Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Obesity Hypoventilation Syndrome Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Obesity Hypoventilation Syndrome Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Obesity Hypoventilation Syndrome Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Obesity Hypoventilation Syndrome Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Obesity Hypoventilation Syndrome Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Obesity Hypoventilation Syndrome Treatment Market Size Markets, 2022 & 2029
        4.1.2 Oxygen Therapy
        4.1.3 Non-invasive Mechanical Ventilation
        4.1.4 Drug Therapy
        4.1.5 Other
    4.2 By Type - Global Obesity Hypoventilation Syndrome Treatment Revenue & Forecasts
        4.2.1 By Type - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Obesity Hypoventilation Syndrome Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Obesity Hypoventilation Syndrome Treatment Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Obesity Hypoventilation Syndrome Treatment Revenue & Forecasts
        5.2.1 By Application - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Obesity Hypoventilation Syndrome Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Obesity Hypoventilation Syndrome Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Obesity Hypoventilation Syndrome Treatment Revenue & Forecasts
        6.2.1 By Region - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Obesity Hypoventilation Syndrome Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Obesity Hypoventilation Syndrome Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2029
        6.3.2 US Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.3.3 Canada Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.3.4 Mexico Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2029
        6.4.2 Germany Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.3 France Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.4 U.K. Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.5 Italy Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.6 Russia Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.4.8 Benelux Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2029
        6.5.2 China Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.5.3 Japan Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.5.4 South Korea Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.5.6 India Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2029
        6.6.2 Brazil Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.6.3 Argentina Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Obesity Hypoventilation Syndrome Treatment Revenue, 2018-2029
        6.7.2 Turkey Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.7.3 Israel Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
        6.7.5 UAE Obesity Hypoventilation Syndrome Treatment Market Size, 2018-2029
7 Obesity Hypoventilation Syndrome Treatment Companies Profiles
    7.1 Accord Healthcare Limited
        7.1.1 Accord Healthcare Limited Company Summary
        7.1.2 Accord Healthcare Limited Business Overview
        7.1.3 Accord Healthcare Limited Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.1.4 Accord Healthcare Limited Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.1.5 Accord Healthcare Limited Key News & Latest Developments
    7.2 Avet Pharmaceuticals Inc
        7.2.1 Avet Pharmaceuticals Inc Company Summary
        7.2.2 Avet Pharmaceuticals Inc Business Overview
        7.2.3 Avet Pharmaceuticals Inc Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.2.4 Avet Pharmaceuticals Inc Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.2.5 Avet Pharmaceuticals Inc Key News & Latest Developments
    7.3 Nostrum Laboratories Inc
        7.3.1 Nostrum Laboratories Inc Company Summary
        7.3.2 Nostrum Laboratories Inc Business Overview
        7.3.3 Nostrum Laboratories Inc Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.3.4 Nostrum Laboratories Inc Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.3.5 Nostrum Laboratories Inc Key News & Latest Developments
    7.4 Lannett Co Inc
        7.4.1 Lannett Co Inc Company Summary
        7.4.2 Lannett Co Inc Business Overview
        7.4.3 Lannett Co Inc Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.4.4 Lannett Co Inc Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.4.5 Lannett Co Inc Key News & Latest Developments
    7.5 Strides Pharma Science Limited
        7.5.1 Strides Pharma Science Limited Company Summary
        7.5.2 Strides Pharma Science Limited Business Overview
        7.5.3 Strides Pharma Science Limited Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.5.4 Strides Pharma Science Limited Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.5.5 Strides Pharma Science Limited Key News & Latest Developments
    7.6 X Gen Pharmaceuticals Inc
        7.6.1 X Gen Pharmaceuticals Inc Company Summary
        7.6.2 X Gen Pharmaceuticals Inc Business Overview
        7.6.3 X Gen Pharmaceuticals Inc Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.6.4 X Gen Pharmaceuticals Inc Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.6.5 X Gen Pharmaceuticals Inc Key News & Latest Developments
    7.7 ResMed
        7.7.1 ResMed Company Summary
        7.7.2 ResMed Business Overview
        7.7.3 ResMed Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.7.4 ResMed Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.7.5 ResMed Key News & Latest Developments
    7.8 Koninklijke Philips NV
        7.8.1 Koninklijke Philips NV Company Summary
        7.8.2 Koninklijke Philips NV Business Overview
        7.8.3 Koninklijke Philips NV Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.8.4 Koninklijke Philips NV Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.8.5 Koninklijke Philips NV Key News & Latest Developments
    7.9 Hikma Pharmaceuticals
        7.9.1 Hikma Pharmaceuticals Company Summary
        7.9.2 Hikma Pharmaceuticals Business Overview
        7.9.3 Hikma Pharmaceuticals Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.9.4 Hikma Pharmaceuticals Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.9.5 Hikma Pharmaceuticals Key News & Latest Developments
    7.10 Lincare Holdings
        7.10.1 Lincare Holdings Company Summary
        7.10.2 Lincare Holdings Business Overview
        7.10.3 Lincare Holdings Obesity Hypoventilation Syndrome Treatment Major Product Offerings
        7.10.4 Lincare Holdings Obesity Hypoventilation Syndrome Treatment Revenue in Global Market (2018-2023)
        7.10.5 Lincare Holdings Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Obesity Hypoventilation Syndrome Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?